Tamoxifen in the treatment of breast cancer.
Osborne
C K
CK
Department of Medicine, University of Texas Health Science Center at San Antonio, 78284-7884, USA.
D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D018567:Breast Neoplasms, Male / Q000188:drug therapy; D017024:Chemotherapy, Adjuvant; D004351:Drug Resistance; D016889:Endometrial Neoplasms / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008593:Menopause; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D013629:Tamoxifen / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen